Long-Acting HIV Treatment May Help Drug-Resistant Cases
Key Takeaways A UCSF study found that long-acting lenacapavir plus cabotegravir maintained viral suppression in 46 people with HIV. All
Read MoreKey Takeaways A UCSF study found that long-acting lenacapavir plus cabotegravir maintained viral suppression in 46 people with HIV. All
Read MoreA recent clinical trial on led by Emory University and Grady Health System has revealed a breakthrough in HIV prevention.
Read More